Chronic fatigue syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) According to the consensus on CFS diagnosis established by CDC in 1994 as follows: 1) persistent or recurrent fatigue lasting more than 6 months; 2) other organic diseases causing chronic fatigue must be excluded based on medical history physical examination or laboratory findings. And meets at least 4 of the following 8 symptom criteria: 1) self-reported impairment in short-term memory or concentration; 2) sore throat; 3) lymph nodes; 4) muscle pain; 5) multijoint pain without redness or swelling; 6) headaches of a new type pattern or severity; 7) unrefreshing sleep; 8) postexertional malaise lasting more than 24 hours. (2) Age =18 years and =65 years; gender is not limited; (3) Those who voluntarily participated in this study and signed the informed consent form.
Exclusion criteria
Exclusion criteria: Subjects will not be enrolled if they meet any of the following criteria (1) Secondary fatigue due to other well-defined causes (e.g. infectious diseases / autoimmune diseases / malignant tumors / hypothyroidism / diabetes mellitus and its complications drug side effects etc.); (2) Accompanied by serious organic diseases or unstable chronic diseases (e.g. cardiovascular / cerebrovascular / hepatic renal / respiratory / hematological immune system diseases / psychosomatic disorders etc.); (3) Those who depend on glucocorticoid therapy for a long period of time and are unable to stop the drug; (4) Bleeding risk (e.g. thrombocytopenia coagulation disorders etc.); (5) Those who received new pharmacologic and non-pharmacologic treatments for CFS and related symptoms within 14 days prior to enrollment; (6) Those with skin disorders or other reasons assessed by the investigator not to be amenable to massage therapy; (7) Persons with anorexia or anorexia nervosa; (8) Currently experiencing suicidal thoughts or comorbid psychiatric disorders that need to be excluded (such as schizophrenia or bipolar disorder). (9) Those who are severely obese with a body mass index (BMI) of >45kg/m2; (10) Pregnant and lactating women; (11) Those who have participated in other clinical trials within 1 month or are participating in other clinical trials; (12) Other conditions judged by the investigator to be unsuitable for participation in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Chalder Fatigue Questionnaire; | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical efficiency;Short-Form 36 physical function subscale (SF-36 PF);Short-Form 36 bodily pain subscale (SF-36 BP);EuroQol five-dimension and three levels EQ-5D-3L; | — |
Countries
China
Contacts
Shuguang hospital affiliated to Shanghai University of Traditional Chinese Medicine